Trials / Completed
CompletedNCT06226649
DDEP for Lifestyle Modification in Chronic Kidney Disease
A Randomized Controlled Feasibility Trial Evaluating the Implementation of Digital Dyadic Empowerment Program (DDEP) on Lifestyle Modification for Chronic Kidney Disease Management
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- National Cheng Kung University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled feasibility trial conducted on patients with Chronic Kidney Disease (CKD) and their significant other
Detailed description
The trial will be conducted on 60 dyads, each comprising a CKD patient and a significant other, who will be randomly assigned into two groups. The intervention group will receive the Digital Dyadic Empowerment Program (DDEP) while the control group will receive routine education and care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Digital Dyadic Empowerment | The Digital Dyadic Empowerment Intervention utilizes LINE, a prominent instant messaging App in Taiwan, integrated with an extended application to deliver comprehensive lifestyle modification support to Chronic Kidney Disease (CKD) dyads. Key features of this intervention include: 1. Access to CKD Health Education Information; 2. Supportive Information for Significant Others; 3. Physiological Values Logging for Self-Monitoring; 4. Reminders for Clinical Appointments and Daily Self-Management Tasks; 5. Kidney Health Diary for Lifestyle Modification Progress Tracking; 6. Frequently Asked Questions (FAQs) and Consultation with Healthcare Providers. This intervention aims to enhance the overall well-being of CKD dyads by promoting education, self-monitoring, adherence to appointments, and efficient communication with healthcare providers. |
Timeline
- Start date
- 2024-01-29
- Primary completion
- 2024-11-08
- Completion
- 2024-12-02
- First posted
- 2024-01-26
- Last updated
- 2025-05-02
- Results posted
- 2025-04-09
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06226649. Inclusion in this directory is not an endorsement.